• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Lifeway Foods Inc. (Amendment)

    2/24/23 7:42:04 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email
    SC 13D/A 1 lifeway_13da15.htm SC 13D/A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 15)*

     

    LIFEWAY FOODS, INC.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    531914109

    (CUSIP Number)

     

    Ludmila Smolyansky
    c/o Lifeway Foods, Inc.
    6431 West Oakton Street

    Morton Grove, IL 60053

    (847) 967-1010

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    February 20, 2022

    (Date of Event Which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [_]

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

       

     

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    Ludmila Smolyansky

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)     [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      2,077,130
     
    8. Shared voting power      0
     
    9. Sole dispositive power      2,077,130
     
    10. Shared dispositive power       0
     
      11.

    Aggregate amount beneficially owned by each reporting person

    2,077,130

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    13.4%

     
      14.

    Type of reporting person (see instructions)

    IN

               

     

     

     2 

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    Edward Smolyansky

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)     [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      2,270,772
     
    8. Shared voting power      500,000
     
    9. Sole dispositive power      2,270,772
     
    10. Shared dispositive power      500,000
     
      11.

    Aggregate amount beneficially owned by each reporting person

    2,770,772

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (see instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    17.9%

     
      14.

    Type of reporting person (see instructions)

    IN

               

     

     

     3 

     

     

    SCHEDULE 13D

    CUSIP No. 531914109

     
      1.

    Names of reporting persons

    The Edward Smolyansky Trust 2/2/16

     
      2. Check the appropriate box if a member of a group (see instructions)
        (a)  [X]
        (b)  [_]
     
      3. SEC use only
     
      4.

    Source of funds (see instructions)

    OO

      5. Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)   [_]
      6.

    Citizenship of place of organization

    United States

     
    Number of
    shares
    beneficially
    owned by
    each
    reporting
    person with
    7. Sole voting power      833,333
     
    8. Shared voting power      0
     
    9. Sole dispositive power      833,333
     
    10. Shared dispositive power      0
     
      11.

    Aggregate amount beneficially owned by each reporting person

    833,333

     
      12. Check if the aggregate amount in Row (11) excludes certain shares (see instructions)   [_]
     
      13.

    Percent of class represented by amount in Row (11)

    5.4%

     
      14.

    Type of reporting person (see instructions)

    OO

               

     

     4 

     

     

    AMENDMENT NO. 15 to SCHEDULE 13D

     

    This Amendment No. 15 further amends and supplements the Schedule 13D filed by Ludmila Smolyansky and Edward Smolyansky (together with The Edward Smolyansky Trust 2/2/16, the “Filing Persons”). This Amendment No. 15 is being filed by the Filing Persons for the purpose of providing the additional information set forth below.

     

    ITEM 2. Identity and Background

     

    Item 2 is hereby amended and supplemented by the addition of the following:

     

    This Schedule 13D is also being filed on behalf of the Edward Smolyansky Trust 2/2/16 (the “Trust”), which as a business address at 1219 N Wells St., Chicago, IL 60610.

     

    ITEM 3. Source and Amount of Funds or Other Consideration

     

    Item 3 is hereby amended and supplemented by the addition of the following:

     

    The Trust holds an aggregate of 833,333 shares of common stock, no par value per share (“Common Stock”), of Lifeway Foods, Inc. (the “Company”), which were received as gifts from Ludmila Smolyansky. The Trust did not use any funds or other consideration to acquire such shares.

     

    Item 4. Purpose of Transaction

     

    Item 4 is hereby amended and supplemented by the addition of the following:

     

    On February 10, 2023, Ludmila Smolyansky and Edward Smolyansky provided a notice to the Company regarding potential breaches of the Settlement Agreement, dated as of July 27, 2022, as amended, among the Company, Ludmila Smolyansky and Edward Smolyansky (the “Settlement Agreement”). Under the Settlement Agreement, Ludmila Smolyansky’s and Edward Smolyansky’s “standstill” obligations under Section 6 of the Settlement Agreement terminate in the event of a material breach by the Company that is not cured within ten days by the Company. On February 22, 2023, the Company provided a written response, claiming that it had not materially breached the Settlement Agreement, and noting that a committee of the Company’s board of directors had approved the engagement of a nationally recognized financial advisor, and that certain terms of the engagement were being negotiated and remained subject to approval by the committee.

     

    The Reporting Persons intend to review their investment in the Company on a continuing basis and may from time to time and at any time in the future depending on various factors, including, without limitation, the Company’s financial position and strategic direction, actions taken by the Board of Directors, price levels of the Company’s securities, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, take such actions with respect to their investment in the Company as they deem appropriate. These actions may include: (i) nominating one or more director candidates for election at the Company’s 2023 annual meeting of shareholders, (ii) acquiring additional shares of Common Stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Company (collectively, “Securities”) in the open market or otherwise; (iii) disposing of any or all of their Securities in the open market or otherwise in each case in accordance with their obligations under the Stockholders’ Agreement, dated October 1, 1999, as amended, and other applicable limitations; (iv) engaging in any hedging or similar transactions with respect to the Securities; or (v) engaging in communications with, without limitation, one or more stockholders of the Company, management of the Company and/or one or more members of the Board of Directors and may make suggestions concerning the Company’s operations, prospects, business and financial strategies, strategic transactions, assets and liabilities, business and financing alternatives, the composition of the Board of Directors and such other matters as the Reporting Persons may deem relevant to their investment in the Company.

     

    The foregoing summary of certain applicable terms of the Settlement Agreement is qualified in its entirety by the Settlement Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on July 29, 2022, and as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on November 9, 2022, and which are incorporated herein by reference.

     

     

     5 

     

     

    ITEM 5. Interest in Securities of the Issuer

     

    Item 5 is hereby amended and supplemented by the addition of the following:

     

    (a)As of February 22, 2023, Ludmila Smolyansky may be deemed for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, to be the beneficial owner of 2,077,130 shares of Common Stock, representing approximately 13.4% of the outstanding shares of Common Stock, Edward Smolyansky may be deemed to be the beneficial owner of 2,770,772 shares of Common Stock, representing approximately 17.9% of the outstanding shares of Common Stock, the Trust may be deemed to be the beneficial owner of 833,333 shares of Common Stock, representing approximately 5.4% of the outstanding shares of Common Stock, and the Filing Persons together may be deemed to be the beneficial owners of an aggregate of 4,847,902 shares of Common Stock, representing approximately 31.3% of outstanding shares of Common Stock. The foregoing percentage calculations were based on 15,473,269 shares outstanding as of November 9, 2022, as reported by the Company on its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, as filed with the SEC, as adjusted to give effect to the cancellation of the Shares repurchased by the Company from Ludmila Smolyansky, as previously disclosed.
       
    (b)Ludmila Smolyansky has sole power to vote or to direct the vote of, and sole power to dispose or direct the disposition of, 2,077,130 shares of Common Stock. Edward Smolyansky has sole power to vote or direct the vote of, and sole power to dispose or direct the disposition of, 2,270,772 shares of Common Stock, which includes the 833,333 shares beneficially owned by the Trust, and shared power to vote or direct the vote of, and shared power to dispose or direct the disposition of, 500,000 shares of Common Stock, which are held by Smolyansky Family Holdings LLC. Edward Smolyansky disclaims beneficial ownership of shares held by Smolyansky Family Holdings LLC, except to the extent of any pecuniary interest therein. The Trust has sole power to vote or direct the vote of, and sole power to dispose or direct the disposition of, 833,333 shares of Common Stock.
       
    (c)Except as set forth below, there have been no transactions in the shares of Common Stock by any of the Filing Persons during the past sixty days:
       
    Date Reporting Person Amount Acquired (Disposed) Price Per Share Type of Transaction
    December 30, 2022 Ludmila Smolyansky (333,333) — Disposition by gift
    December 30, 2022 Trust 333,333 — Acquisition by gift
    January 13, 2023 Edward Smolyansky (5,000) $6.00 Open market sale

     

    ITEM 6.Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

     

    Item 6 is hereby amended and supplemented by the addition of the information set forth in the second paragraph of Item 4 of this Amendment No. 15.

     

    ITEM 7.Material to be Filed as Exhibits

     

    99.1       Joint Filing Agreement

     

     

     6 

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

     

    Date: February 23, 2023 /s/ Ludmila Smolyansky                      
    Ludmila Smolyansky

     

    Date: February 23, 2023 /s/ Edward Smolyansky                       
    Edward Smolyansky

     

      THE EDWARD SMOLYANSKY TRUST 2/2/16
       
    Date: February 23, 2023 By: /s/ Edward Smolyansky                 
    Name: Edward Smolyansky
      Title: Trustee

     

     

     

     

     

     7 

     

    Get the next $LWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    9/25/2023Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lifeway Foods downgraded by Noble Capital Markets

      Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

      9/24/24 8:32:49 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods upgraded by Noble Capital Markets with a new price target

      Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

      5/30/24 9:15:56 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lake Street initiated coverage on Lifeway Foods with a new price target

      Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00

      4/5/24 8:42:53 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Edward Smolyansky Rebukes Lifeway Foods (NASDAQ: LWAY) 2024 Amended 10-K Filing

      CHICAGO, May 2, 2025 /PRNewswire/ -- Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation. Apparent Delay of 2025 Annual Meeting of Shareholders On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate. "The filing of the amended 2024 Annual Report, and other steps taken recently by the Company,

      5/2/25 12:50:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Lifeway Foods Inc.

      10-Q - Lifeway Foods, Inc. (0000814586) (Filer)

      5/13/25 9:00:23 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 6:46:02 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form 10-K/A filed by Lifeway Foods Inc.

      10-K/A - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 4:15:08 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $LWAY
    Financials

    Live finance-specific insights

    See more
    • CEO, President and Secretary Smolyansky Julie sold $1,103,500 worth of shares (50,000 units at $22.07), decreasing direct ownership by 2% to 2,132,483 units (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/20/25 3:12:39 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $891,927 worth of shares (37,482 units at $23.80) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/5/25 4:50:03 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $487,769 worth of shares (20,518 units at $23.77) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/1/25 5:01:56 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 4:33:49 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 8:53:57 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      9/23/24 4:07:26 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

      Company achieves 2024 net sales of $186.8 million; up 17% year-over-year 21st consecutive quarter of year-over-year growth Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024. "I am pleased to report another reco

      3/14/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples